A third health system has started using Cytovale’s early sepsis detection test. Froedtert & the Medical College of Wisconsin Health Network announced its plans to deploy the diagnostic test this week.
Cytovale, a San Francisco-based medical diagnostics company, raised $84 million in Series C funds to advance the commercialization of its diagnostic test for early sepsis detection. Using standard blood draws, the test provides results in under 10 minutes. It is meant to detect sepsis in patients who present to hospital emergency departments.
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
Earlier this week, Launchpad Studio, an acceleration program, unveiled its first cohort of machine learning-focused startups. Throughout the six-month program, the four companies will work with experts from Silicon Valley and Google.